Transient suppression of the ECM1 gatekeeper is essential for HGF/c-MET-driven liver regeneration
Ye YaoiD, Yujia LiiD, Chenjun HuangiD, Jiayi Ma, Liang Xu, Stephanie D. WolfiD, Julian Gilljam, Haifeng Zeng, Stefan MunkeriD, Xioachun Cao-Ehlker, Ruochan Li, Bernhard Willibald RenziD, Hanno NießiD, Seddik HammadiD, Elisa Holstein, Laura Danielczyk, Roman LiebeiD, Honglei Weng, Ursula KlingmülleriD, Matthias P. A. Ebert, Chunfang GaoiD, J G Bode, Donato InversoiD, Peter ten DijkeiD, S Wang, , Sai WangiD
Abstract
Hepatocyte growth factor (HGF) is a multifunctional cytokine stored in the extracellular matrix as an inactive precursor and is essential for tissue repair. How HGF activity is dynamically regulated during regeneration remains unclear. Here, we identify extracellular matrix protein 1 (ECM1) as a physiological inhibitor of active HGF during liver regeneration. Following 70% partial hepatectomy, active HGF rapidly increases in parallel with a sharp decline in ECM1, and preventing this downregulation delays liver mass recovery. Mechanistically, ECM1 directly binds the active HGF -subunit through a mechanism dependent on residue R392, thereby suppressing c-MET-ERK-MYC signaling and hepatocyte proliferation. Loss of ECM1 permits activation of this pathway, whereas MYC overexpression rescues ECM1-mediated growth inhibition. In patients, proliferative hepatocytes localize to ECM1-negative regions. Supported by transcriptomic analyses and computational modeling, these findings identify ECM1 as an extracellular gatekeeper whose transient downregulation enables HGF-driven tissue repair. HighlightsO_LIECM1 is temporally downregulated during liver regeneration, while forced ECM1 expression delays liver mass recovery after 70% PHx by suppressing hepatocyte proliferation. C_LIO_LIRapid and transient ECM1 downregulation permits HGF-c-Met-ERK-MYC signaling to drive hepatocyte cell-cycle entry and expansion. C_LIO_LIECM1 directly binds the active HGF -subunit with residue R392 playing a critical role, revealing a novel extracellular mechanism for growth factor inhibition. C_LIO_LILoss of ECM1 marks proliferative hepatocytes in human liver repair, identifying ECM1 as a tunable regulator of regenerative capacity. C_LI
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The LIF-LIFR Axis Promotes Liver Regeneration via Modulation of Angiogenesis and HGF Release from LSECs
Wenjing Zhou, Tanja Diemer, … Napoleone Ferrara·bioRxiv·Feb 25, 2026
- Hepatocyte Nuclear Factor 4 alpha (HNF4α) Activation is Essential for Termination of Liver Regeneration
I. Huck, S. Gunewardena, … U. Apte·bioRxiv·Apr 20, 2018
- Survival of hepatocytes from executioner caspase activation promotes liver regeneration by enhancing JAK/STAT3 activity
Zhiyuan Cao, Lining Qin, … Gongping Sun·bioRxiv·Aug 28, 2024
- Cellular plasticity balances the metabolic and proliferation dynamics of a regenerating liver
Ullas Valiya Chembazhi, Sushant Bangru, … Auinash Kalsotra·Genome ResearchPeer-reviewed·Apr 1, 2021
- Dimerization of kringle 1 domain from hepatocyte growth factor/scatter factor provides a potent minimal MET receptor agonist.
G. de Nola, B. Leclerc, … J. Vicogne·bioRxiv·Jul 20, 2020
- Balance Between EGF/STAT1 and IFNγ/NRF2 Signaling Controls ECM1 Expression and Determines Hepatic Homeostasis versus Chronic Liver Disease
Yujia Li, Chenjun Huang, … Sai Wang·bioRxiv·Feb 17, 2024